| Bioactivity | DB2115 (tertahydrochloride) is a potent inhibitor of myeloid master regulator PU.1. DB2115 (tertahydrochloride) has the potential for researching cancers, including hematologic cancers such as leukemia, as well as other conditions associated with PU. 1 dysfunction (extracted from patent WO2017223260A1, compound DB2115) [1]. |
| Name | DB2115 tertahydrochloride |
| CAS | 1366126-19-3 |
| Formula | C32H34Cl4N8O2 |
| Molar Mass | 704.48 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
DB2115 tertahydrochloride
CAS: 1366126-19-3 F: C32H34Cl4N8O2 W: 704.48
DB2115 (tertahydrochloride) is a potent inhibitor of myeloid master regulator PU.1. DB2115 (tertahydrochloride) has the
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.